AIM: To examine the relation of doxapram to a developmental score achieved by a structured telephone interview in a group of extremely-preterm-born children.
METHODS: Parents of 88 children born extremely preterm were contacted by telephone and interviewed by a structured questionnaire (R-PDQ) when the corrected age of their child was 9-15 mo.
RESULTS: We found that doxapram treatment was associated with a deficit in age-adjusted R-PDQ score.
CONCLUSION: Doxapram may have a negative effect on neurodevelopmental outcome.
|Number of pages||2|
|Publication status||Published - Nov 2005|
- Case-Control Studies
- Developmental Disabilities
- Infant, Newborn
- Infant, Premature
- Infant, Very Low Birth Weight
- Linear Models
- Respiratory System Agents